P&G Given Green Light To Offload Haliborange Supplements
Executive Summary
P&G's decision to offload its Haliborange children's supplement line will not lead to reduced competition in the UK market, according to the regulator.
You may also be interested in...
P&G Lacks Evidence To Support Vicks Efficacy Claims In UK Ad
Procter & Gamble failed to substantiate claims that Vicks First Defence can eliminate cold symptoms completely, says UK ad regulator ASA.
UK Wellness Launches: Baby Probiotics, His & Her Gummies And Vegan Q10
Latest dietary supplement launches in the UK featuring Wren Laboratories' For your baby probiotic; Vitabiotics' adult gummies formulated for men and women; and Pharma Nord's reformulated vegan Q10.
P&G signals its intent with Merck acquisition
Procter & Gamble (P&G) is set to acquire for €3.4 billion Merck KGaA’s Consumer Health business, in a move the consumer- goods giant claims will improve significantly its “geographic scale, brand portfolio and category footprint” in the world’s leading OTC markets. Subject to regulatory approvals, the transaction is expected to close by the end of the fourth quarter.